EU grants 3.3 million to AMP for gene therapy development against AIP
Links shared publicly online about this topic.
- 541total visits
EU grants 3.3 million to AMP for gene therapy development against AIP
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Union has finalized a EUR 3.3 million grant to the AIPGENE consortium, of which AMT is a member, for the development of a gene therapy product for Acute Intermittent Porphyria.
View full resource at news-medical.net
Tags: Genes
Most Recently Shared on January 31, 2011 at 7:33 am By:
RT @Parkinsons_News: EU grants 3.3 million to AMP for gene therapy development against AIP: Amsterdam Molecular ... http://bit.ly/eXMKop
Also Shared By:
Advertisement
News-Medical.Net
@Parkinsons_News
Parkinson's Disease: EU grants 3.3 million to AMP for gene therapy development against AIP: Amsterdam Molecular ... http://bit.ly/eXMKop
1 year ago...